Adagio Medical (ADGM) Stock Price, News & Analysis

Company Overview

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

Key Stats

• Today's Range: $1.00 to $1.11
• 50-Day Range: $0.81 to $1.78
• 52-Week Range: $0.63 to $9.34
• Volume: 15,861 shs
• Average Volume: 734,082 shs
• Market Capitalization: $16.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ADGM Stock Analysis - Frequently Asked Questions

How have ADGM shares performed this year?

Adagio Medical's stock was trading at $1.05 on January 1st, 2025. Since then, ADGM shares have increased by 4.8% and is now trading at $1.10.
View the best growth stocks for 2025 here.

How were Adagio Medical's earnings last quarter?

Adagio Medical Holdings, Inc. (NASDAQ:ADGM) posted its quarterly earnings results on Thursday, May, 15th. The company reported ($0.51) earnings per share for the quarter.

Who are Adagio Medical's major shareholders?

Top institutional shareholders of Adagio Medical include Adage Capital Partners GP L.L.C. (4.55%).

How do I buy shares of Adagio Medical?

Shares of ADGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Adagio Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Adagio Medical investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 6/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Trading
• Current Symbol: NASDAQ:ADGM
• Previous Symbol: NASDAQ:ADGM
• CIK: 2006986
• Web: adagiomedical.com
• Phone: (212) 284-2300
• Fax: N/A
• Employees: 87
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$75.04 million
• Net Margins: N/A
• Pretax Margin: -12,975.00%
• Return on Equity: -274.60%
• Return on Assets: -151.76%

Debt

• Debt-to-Equity Ratio: 1.42
• Current Ratio: 2.89
• Quick Ratio: 2.51

Sales & Book Value

• Annual Sales: $600 thousand
• Price / Sales: 28.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.31 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 15,380,000
• Free Float: 7,160,000
• Market Cap: $16.92 million
• Optionable: N/A
• Beta: 0.04